Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
ACS Applied Materials & Interfaces|May 24, 2017
Injectable, NIR/pH-Responsive Nanocomposite Hydrogel as Long-Acting Implant for Chemophotothermal Synergistic Cancer TherapyXiaoyu Xu, Ziyuan Huang, Zeqian Huang, et al.Theranostics|September 20, 2019
Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitorZeqian Huang, Gaofei Wei, Zishan Zeng, et al.Carbohydrate Polymers|December 13, 2019
Near-infrared light-triggered degradable hyaluronic acid hydrogel for on-demand drug release and combined chemo-photodynamic therapyXiaoyu Xu, Zishan Zeng, Zeqian Huang, et al.European Journal of Medicinal Chemistry|April 9, 2018
A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapyLiangfeng Huang, Gaofei Wei, Xiaoqi Sun, et al.Biomaterials|April 10, 2022
Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapyJie Chen, Xiaomin Tan, Yanjuan Huang, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 2, 2021
Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapyMeixu Chen, Zeqian Huang, Meng Xia, et al.International Journal of Pharmaceutics|May 7, 2021
Reduction-responsive dehydroepiandrosterone prodrug nanoparticles loaded with camptothecin for cancer therapy by enhancing oxidation therapy and cell replication inhibitionCongjun Xu, Haolan Yang, Zhanghong Xiao, et al.Acta Biomaterialia|August 16, 2024
A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imagingYaqing Ding, Zeqian Huang, Yong Luo, et al.Journal of Materials Chemistry. B|April 8, 2020
Near infrared light triggered reactive oxygen species responsive nanoparticles for chemo-photodynamic combined therapyXuefei Zhang, Binyao Huang, Yifeng Shen, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2022
Bortezomib prodrug catalytic nanoreactor for chemo/chemodynamic therapy and macrophage re-educationYanjuan Huang, Zilin Guan, Lingling Ren, et al.Pageof 3